# Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test

> **NCT04557046** · NA · UNKNOWN · sponsor: **LumiraDx UK Limited** · enrollment: 1134 (actual)

## Conditions studied

- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** Nasal Swab
- **DIAGNOSTIC_TEST:** Nasopharyngeal swab
- **DIAGNOSTIC_TEST:** Throat swab
- **DIAGNOSTIC_TEST:** Fingerstick
- **DIAGNOSTIC_TEST:** Saliva specimen

## Key facts

- **NCT ID:** NCT04557046
- **Lead sponsor:** LumiraDx UK Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-26
- **Primary completion:** 2021-03-24
- **Final completion:** 2024-03-31
- **Target enrollment:** 1134 (ACTUAL)
- **Last updated:** 2023-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04557046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04557046, "Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04557046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*